ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 786,93
1,43%
DAX
18 518,03
-0,44%
Brent Oil
83,305
-1,23%
Bitcoin
64 279,32
-0,88%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
17/04/201521h23Dow Jones NewsTeva Pharmaceutical Considering Bid for MylanNYSE:TEVATeva Pharmaceutical Industries Ltd.
17/04/201514h59Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
17/04/201514h00Business WireTeva to Report First Quarter 2015 Financial Results on April 30, 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
16/04/201523h15The Motley FoolWhy Momenta Pharmaceuticals Inc. Shares Are Surging HigherNYSE:TEVATeva Pharmaceutical Industries Ltd
16/04/201522h51Dow Jones NewsFDA Approves Generic Multiple-Sclerosis Drug by Novartis's Sandoz and Momenta -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
16/04/201522h07Dow Jones NewsFDA Approves Novartis and Momenta's Generic Multiple-Sclerosis DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
14/04/201514h00Business WireTeva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for FilingNYSE:TEVATeva Pharmaceutical Industries Ltd
13/04/201514h00Business WireTeva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.NYSE:TEVATeva Pharmaceutical Industries Ltd
03/04/201523h30PR Newswire (US)SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Auspex Pharmaceuticals, Inc. Over the Proposed Sale of...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/04/201517h37PR Newswire (US)WeissLaw LLP: The Auspex Pharmaceuticals, Inc. Acquisition by Teva Pharmaceutical Industries Is the Subject of a Legal Invest...NYSE:TEVATeva Pharmaceutical Industries Ltd
02/04/201514h00Business WireTeva and Xenon Announce Enrollment of First Patient in a Phase 2b Study Evaluating TV-45070 for Postherpetic Neuralgia (PHN)NYSE:TEVATeva Pharmaceutical Industries Ltd
01/04/201514h00Business WireTeva Announces FDA Approval of ProAir® RespiClickNYSE:TEVATeva Pharmaceutical Industries Ltd
31/03/201514h30Business WireTeva Expands Hypertension Line with Launch of Generic Exforge® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
31/03/201513h07The Motley FoolThe Single Worst Practice of the Drug IndustryNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201523h12Dow Jones NewsADR Shares End Higher; Carnival Shares RiseNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201522h38Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Rally Amid China Easing Hints, Deal NewsNYSE:TEVATeva Pharmaceutical Industries Ltd.
30/03/201519h43The Motley FoolHealthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout TargetsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201519h36The Motley FoolWhy Auspex Pharmaceuticals, Inc. Stock Soared TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201516h50PR Newswire (US)AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201515h40Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks: Futures Rebound As Bulls Run With Yellen; Chinese Hints EasingNYSE:TEVATeva Pharmaceutical Industries Ltd.
30/03/201514h14Dow Jones NewsTeva to Acquire Auspex in $3.2 Billion DealNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201513h43Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks: Futures Rebound As Bulls Run With Yellen, Chinese Easing HintsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/03/201513h00Business WireTeva Reinforces Leadership Position in CNS with Acquisition of AuspexNYSE:TEVATeva Pharmaceutical Industries Ltd
24/03/201521h41Business WireTeva Announces Pricing of €2 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201514h59Dow Jones NewsTeva Migraine Therapy Shows Positive Results in Phase IIb StudyNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201514h00Business WireTeva Announces New Head of Business Development, Strategy and InnovationNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201513h46Business WireTeva’s TEV-48125 Meets Primary & Secondary Endpoints in Episodic Migraine Study, Demonstrating Treatment Concept After a Si...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/03/201521h00Business WireTeva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/201521h00GlobeNewswire Inc.Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
05/03/201515h01Business WireTeva to Present at the Barclays Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
EN
Bouygues
NYSE
NKE
Nike
EU
PX1
CAC 40
EU
HO
Thales
EU
SGO
Cie de SaintGobain
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
EU
PX4
SBF 120
NYSE
MRK
Merck
EU
VK
Vallourec
EU
ACA
Credit Agricole
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés